Last mentioned: Mar 4, 2026
Agreement Review
Conclusion of the initial three-year strategic term and evaluation of commercial results.
Phase 1 Launch
Rollout of the 'AI Digital Health Manager' SaaS system for sub-healthy users.
Phase 1 Launch
Initial rollout of the 'AI Digital Health Manager' SaaS system targeting sub-healthy demographics.
Partnership Announcement
HAOXI Health and Eaglepoint AI sign a 3-year strategic agreement.
Partnership Announcement
HAOXI Health and Eaglepoint AI sign a three-year strategic cooperation agreement.
Partnership Announcement
Signing of the three-year strategic cooperation agreement in Beijing.
R&D Expansion
Integration of multimodal models for chronic disease risk assessment.
Strategic R&D
Ongoing joint commitment of R&D, data, and channel resources for AI health management.
Haoxi Health and Eaglepoint AI have entered a three-year strategic partnership to launch an AI-powered health management platform in China. The collaboration will leverage the Aquila data engine to develop digital therapeutics and chronic disease assessment tools.
HAOXI Health Technology and Eaglepoint AI have signed a three-year strategic agreement to develop an AI-powered health management platform for the Chinese market. The collaboration will leverage Eaglepoint’s Aquila data engine and HAOXI’s marketing reach to launch the 'AI Digital Health Manager' SaaS system.
HAOXI Health Technology and Eaglepoint AI have entered a three-year strategic partnership to launch an AI-driven health management platform in China. The collaboration integrates the Aquila data engine and multimodal AI models to target chronic disease assessment and digital therapeutics for sub-healthy populations.